CClinicalTrials.gg
CompletedNCT01302730Updated Nov 8, 2013

Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study

An observational study in Ankylosing Spondylitis and Spondylarthritis, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-11-08.

Sponsored by Stanford University · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
490
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to test whether a new instrument (questionnaire) is useful for identifying patients with ankylosing spondylitis.

02

Conditions studied

  • Ankylosing Spondylitis
  • Spondylarthritis

Keywords

  • ankylosing spondylitis
  • spondylarthritis
  • inflammatory back pain
  • seronegative
03

In context

Spondylitis

623 studies on the registry are indexed under Spondylitis; 83 are open to participants now.

This study's enrollment of 490 is above the median of 202 across 256 observational studies indexed under Spondylitis.

Browse Spondylitis studies →

Lead sponsor

Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.

Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients referred to rheumatologist office will be potentially eligible.

Inclusion criteria

  • Ability to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Inability to provide informed consent
05

Study design

Time perspective
Prospective
Enrollment
490 participants (actual)
06

What researchers measure

Primary outcomes

  1. Physician diagnosis of Ankylosing Spondylitis

    Time frame: 6 months

07

Study locations

1 site
  • Stanford University
    Stanford, California 94304, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01302730
Lead sponsor
Stanford University
Collaborators
University of California, San Francisco, Oregon Health and Science University, Cedars-Sinai Medical Center
Responsible party
Eswar Krishnan (ASSISTANT PROFESSOR, Stanford University) — Principal investigator
First posted
Feb 24, 2011
Start date
Apr 2011
Primary completion
Mar 2012
Completion
Nov 2013
Last update
Nov 8, 2013

Study contacts

Eswar Krishnan
principal investigator · Stanford University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion